Sonoma Pharmaceuticals (SNOA) Debt Ratio (2011 - 2026)

Sonoma Pharmaceuticals' Debt Ratio history runs 16 years deep, the most recent figure standing at 0.02 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 1.02% year-over-year to 0.02 in Q1 2026; TTM through Mar 2026 was 0.02, a 1.02% decrease from a year earlier, with the FY2026 full-year figure at 0.02, down 1.02% from the prior year.
• Debt Ratio advanced to 0.02 in Q1 2026 per SNOA's latest filing, from 0.0 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.04 in Q1 2022 and bottomed at 0.0 in Q4 2022.
• The 5-year median for Debt Ratio is 0.02 (2026), against an average of 0.02.
• Across the five-year window, Debt Ratio plunged 96.45% in 2022 and jumped 179.49% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.0 in 2022, then soared by 179.49% to 0.0 in 2023, then surged by 99.07% to 0.01 in 2024, then sank by 32.55% to 0.0 in 2025, then soared by 293.48% to 0.02 in 2026.
• Per Business Quant, the three latest SNOA Debt Ratio figures stand at 0.02 (Q1 2026), 0.0 (Q3 2025), and 0.01 (Q2 2025).